Isr Med Assoc J
The most recent articles from:
Isr Med Assoc J
-
Belimumab was the first biological drug approved for the treatment of systemic lupus erythematosus (SLE) patients. Phase II/III randomized controlled trials and real-life studies identified patients with musculoskeletal involvement as best responders. ⋯ Belimumab induces a sustained improvement of ultrasound-detected inflammatory status at the articular level.